131 related articles for article (PubMed ID: 4206914)
1. A new case of mu heavy chain disease: clinical and immunochemical studies.
Dammacco F; Bonomo L; Franklin EC
Blood; 1974 May; 43(5):713-9. PubMed ID: 4206914
[No Abstract] [Full Text] [Related]
2. [Principal characteristics of heavy chain diseases].
Seligmann M
Bull Cancer; 1972; 59(4):381-8. PubMed ID: 4201934
[No Abstract] [Full Text] [Related]
3. Mu-chain disease.
Lee SL; Rosner F; Ruberman W; Glasberg S
Ann Intern Med; 1971 Sep; 75(3):407-14. PubMed ID: 5568152
[No Abstract] [Full Text] [Related]
4. Heavy chain disease of the gamma (gamma M) type: report of the first case.
Forte FA; Prelli F; Yount WJ; Jerry LM; Kochwa S; Franklin EC; Kunkel HG
Blood; 1970 Aug; 36(2):137-44. PubMed ID: 4193528
[No Abstract] [Full Text] [Related]
5. MU-chain disease in an African patient.
Bonhomme J; Seligmann M; Mihaesco C; Clauvel JP; Danon F; Brouet JC; Bouvry P; Martine J; Clerc M
Blood; 1974 Apr; 43(4):485-92. PubMed ID: 4361394
[No Abstract] [Full Text] [Related]
6. [Principle of antibody structure. The primary structure of a monoclonal kappa I-type immunoglobulin L-chain aggregate forms, (Bence Jones protein Bi). I. Purification, and characterization of the protein].
Leibold W; Braun M; Gottschalk EM; Hilschmann N
Hoppe Seylers Z Physiol Chem; 1972 Aug; 353(8):1259-72. PubMed ID: 4628263
[No Abstract] [Full Text] [Related]
7. [Heavy chain disease. A case of IgG-heavy-chain-fragment and IgM-type K-paraproteinemia with plasma cell leukemia].
Keller H; Spengler GA; Skvaril F; Flury W; Noseda G; Riva G
Schweiz Med Wochenschr; 1970 Jun; 100(24):1012-22. PubMed ID: 5004028
[No Abstract] [Full Text] [Related]
8. Immunochemical analysis of IgD-lambda paraprotein in myeloma.
Tichý M; Hrncír Z; Pola V; Mazák J
Neoplasma; 1974; 21(4):487-91. PubMed ID: 4215041
[No Abstract] [Full Text] [Related]
9. Double paraprotein aemias (IgMK plus IgGK and IgGK plus BJL).
Péter K; Ottó S
Ann Immunol Hung; 1972; 16(0):319-27. PubMed ID: 4213040
[No Abstract] [Full Text] [Related]
10. Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases.
Preud'homme JL; Seligmann M
Blood; 1972 Dec; 40(6):777-94. PubMed ID: 4628444
[No Abstract] [Full Text] [Related]
11. Immunoglobulin disturbances and their clinical significance.
Solomon A; McLaughlin CL
Med Clin North Am; 1973 Mar; 57(2):499-516. PubMed ID: 4632920
[No Abstract] [Full Text] [Related]
12. Technical aspects of the detection and characterization of immunoglobulin dyscrasis.
Conway BP
Health Lab Sci; 1972 Jul; 9(3):185-96. PubMed ID: 4625660
[No Abstract] [Full Text] [Related]
13. A new variant of heavy-chain disease (mu-chain disease).
Ballard HS; Hamilton LM; Marcus AJ; Illes CH
N Engl J Med; 1970 May; 282(19):1060-2. PubMed ID: 5438427
[No Abstract] [Full Text] [Related]
14. Heavy chain diseases.
Seligmann M
Rev Eur Etud Clin Biol; 1972 Apr; 17(4):349-55. PubMed ID: 4627944
[No Abstract] [Full Text] [Related]
15. Transplantable immunoglobulin-secreting tumours in rats. Purification and chemical characterization of four kappa chains from LOU-Wsl rats.
Querinjean P; Bazin H; Beckers A; Deckers C; Heremans JF; Milstein C
Eur J Biochem; 1972 Dec; 31(2):354-9. PubMed ID: 4630505
[No Abstract] [Full Text] [Related]
16. [ -Chain disease].
Germann HJ; Westerhausen M; Kickhöfen B
Dtsch Med Wochenschr; 1972 Dec; 97(49):1902-5. PubMed ID: 4629316
[No Abstract] [Full Text] [Related]
17. Mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. II. Immunochemical studies.
Axelsen NH; Harboe M; Jonsson V; Videbaek AA
Scand J Haematol; 1976 Mar; 16(3):218-25. PubMed ID: 179131
[TBL] [Abstract][Full Text] [Related]
18. Two serologically distinguishable subclasses of mu-chains of human macroglobulins.
Franklin EC; Frangione B
J Immunol; 1967 Oct; 99(4):810-4. PubMed ID: 4963796
[No Abstract] [Full Text] [Related]
19. Characterization of the Fv fragment isolated from a human immunoglobulin M.
Kakimoto K; Onoue K
J Immunol; 1974 Apr; 112(4):1373-82. PubMed ID: 4205527
[No Abstract] [Full Text] [Related]
20. [Combined features of mu-heavy chain disease and primary macroglobulinemia in a single patient: clinical and immunological studies].
Fujii H; Shimizu T; Seki S; Isemura T; Yamamoto K; Kanoh T; Ohno Y
Nihon Ketsueki Gakkai Zasshi; 1982 May; 45(3):622-32. PubMed ID: 6814143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
